Concepedia

Amy R. Saklad

AR

7

Publications

1.5K

Citations

7

H-Index

2002

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

The University of Texas Health Science Center at San Antonio

Stanford University

International University of Health and Welfare

National Hospital Organization Hanamaki Hospital

Amy R. Saklad is an author at Alexion Pharmaceuticals (United States) specializing in medicine and pharmacology.

Top concepts

Publications per year

2002–2024

7

Publications

7

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Neuropsychiatric syndromes in lupus

Robin L. Brey, Stephen L. Holliday, Amy R. Saklad et al. · Neurology · 2002 · 594 citations

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Validating a computerized neuropsychological test battery for mixed ethnic lupus patients

Stephen L. Holliday, Marta Navarrete, David Hermosillo-Romo et al. · Lupus · 2003 · 60 citations

Cerebral small vessel disease burden is associated with decreased abundance of gut Barnesiella intestinihominis bacterium in the Framingham Heart Study

Bernard Fongang, Claudia L. Satizábal, Tiffany F. Kautz et al. · Scientific Reports · 2023 · 25 citations · Full text

Rows per page

1–5 of 7